News Google defectors set up AI-based scientific method company Four top AI figures at Google have left to form their own startup – Discovery Loop – dedicated to 'automating the experimental loop' in R&D.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.